Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02424383 · ClinicalTrials.gov registry record · NA
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 1,005
- Enrollment target
NCT02424383: Completed NA study, sponsored by C. R. Bard.
NCT02424383 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 1,005 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02424383, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,005 participants
- Enrollment target
Study Summary
The objective of this patient registry is to assess the clinical use of the Lutonix 035 DCB PTA Catheter in a heterogeneous patient population in a real world and on-label clinical application.
Primary Outcome
TLR is defined as the first revascularization procedure (e.g. Percutaneous Transluminal Angioplasty (PTA), stenting, etc.) of the target lesion after the index procedure.
Interventions
- DEVICE PTA (Lutonix® 035 DCB Catheter)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,005 participants |
| Start Date | 2015-04-23 |
| Est. Completion | 2019-10-21 |
| Phase | NA |
What the finished NCT02424383 record still lists
NCT02424383 is an interventional study that assigns participants to a tested intervention. Its 1,005 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower).
The record links to 0 conditions, and to 1 intervention - of which PTA (Lutonix® 035 DCB Catheter) is the first listed.
NCT02424383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02424383 about?
NCT02424383 is a clinical study titled "Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter". The objective of this patient registry is to assess the clinical use of the Lutonix 035 DCB PTA Catheter in a heterogeneous patient population in a real world and on-label clinical application.
What is the current status of trial NCT02424383?
This trial is currently completed. It is a NA study. The enrollment target is 1,005 participants. The study started on 2015-04-23. Estimated completion is 2019-10-21.
What interventions are being tested in trial NCT02424383?
The interventions under investigation include: PTA (Lutonix® 035 DCB Catheter) (DEVICE).
Who is sponsoring clinical trial NCT02424383?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02424383's enrollment target sits among peer trials
1,005 106th of 2000 higher than 1,895 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI